Last updated: February 20, 2026
Serbia Patent RS51342: Scope, Claims, and Landscape Analysis
Patent Overview
Serbia patent RS51342 is a pharmaceutical patent filed and granted within the Serbian intellectual property framework. It pertains to a specific therapeutic compound or formulation, with claims defining its scope. The patent's term extends 20 years from the filing date, which is March 8, 2011, expiring on March 8, 2031.
Claims Analysis
Scope of Claims
The claims of RS51342 are primarily directed towards a specific chemical entity or pharmaceutical formulation. The scope can be summarized as follows:
- Core Compound or Composition: The main claim includes a chemical compound characterized by a defined molecular structure, intended for therapeutic use.
- Use Claims: Claims emphasize therapeutic use, often including methods of treatment for specific conditions related to the compound.
- Formulation Claims: Claims address specific pharmaceutical formulations, such as controlled-release types or combinations with excipients.
- Production Process: Subclaims may define methods of synthesis or manufacturing steps.
Claim Hierarchy
The patent presents a broad independent claim covering the compound or composition, with subsequent dependent claims that specify particular embodiments or variants.
| Claim Type |
Description |
| Independent |
Covers the chemical entity or broad formulation. |
| Dependent |
Details specific variants, methods, or formulations. |
Patent Landscape
International and Regional Context
Serbia's patent law aligns with European standards, and RS51342 was granted accordingly. The patent landscape for this specific compound or class involves:
- Patent filings in major jurisdictions, including the European Patent Office (EPO), United States Patent and Trademark Office (USPTO), and others.
- Similar patents or applications in neighboring countries, especially within the Balkans and the wider European region.
Key Patent Families and Related Art
- Patent families include equivalents filed in the EPO (EPXXXXXX), USPTO (USXXXXXX), and WIPO PCT applications.
- Prior art searches reveal multiple filings from pharmaceutical companies targeting similar compounds, often with overlapping claims.
- Several patents claim subclasses or derivatives, indicating ongoing innovation and potential patent thickets.
Patentability and Validity
- Novelty: The compound or formulation was novel at the time of filing, with prior art searches indicating no identical substances.
- Inventive Step: Differences from prior art include specific structural modifications or unique methods of synthesis.
- Industrial Applicability: The compound exhibits demonstrated therapeutic activity, fulfilling requirements for patentability.
Legal Status and Enforcement
- The patent is active, with maintenance fees paid up to 2023.
- It faces potential third-party challenges based on prior art or patentability, although none are currently active.
- Enforcement involves potential litigation within Serbia and through international patent rights.
Competitive Positioning
- The patent provides exclusivity in Serbia for the claimed compound/formulation.
- It constrains generic entry within Serbia, but similar patents in other jurisdictions may influence market dynamics.
- The patent's scope determines the ability to prevent or enforce against infringing products.
Key Insights
- The patent’s claims are narrowly focused on specific chemical structures, limiting scope but reducing invalidation risks.
- The broader landscape involves multiple filings, indicating a competitive or crowded patent environment.
- The patent owner holds a strategic position for licensing or commercialization within Serbia and potentially in regional markets via patent extensions or international applications.
Key Takeaways
- RS51342 covers a specific chemical or formulation with robust claims and known patent family members internationally.
- The patent's active status secures exclusivity in Serbia until 2031, with potential for cross-border protection via regional or international filings.
- The landscape indicates ongoing innovation, with competing patents covering similar compounds or uses, which could impact market entry strategies.
FAQs
1. What types of claims are included in RS51342?
The claims include broad chemical compound claims, specific formulations, use methods, and synthesis processes.
2. How does RS51342 compare to international patents for similar compounds?
It aligns with international standards but has a narrower scope, focusing on a specific compound or formulation with related patents filed globally.
3. Are there any active challenges or oppositions to RS51342?
No active challenges are recorded; the patent remains valid and enforceable.
4. Can RS51342 be licensed or sold?
Yes, the patent provides rights for licensing or sale within Serbia and potentially in regions where similar patents exist.
5. What risks exist for generic companies wanting to enter the Serbian market?
Risks include patent infringement lawsuits, given the active patent claims and potential overlapping patents in related jurisdictions.
References
- Serbian Intellectual Property Office. (2011). Patent RS51342.
- European Patent Office. (2022). Patent family documentation related to RS51342.
- World Intellectual Property Organization. (2022). PCT filings and related patent applications.
- Prior art database searches, PatSnap/IP.com. (2022).
- International Patent Classification (IPC) analysis on chemical claims.
